Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

[1] Kvien TK(2004)Epidemiology and burden of illness of rheumatoid arthritis Pharmacoeconomics 22 1-12

[2] Shaw Y(2018)Responding resiliently to chronic disease: rheumatoid arthritis patients’ discourse on coping strategies and challenges Ann Rheum Dis 77 abstract FRI0740-HPR-2293

[3] Bradley M(2018)Understanding the burden of rheumatoid arthritis using qualitative research: which impacts are not captured by patient-reported measures? Ann Rheum Dis 77 abstract FRI0725-HPR-393

[4] Dominique A(2018)Understanding fatigue burden and coping strategies in rheumatoid arthritis using qualitative research Ann Rheum Dis 77 abstract AB1444-HPR-2344

[5] Michaud K(2002)Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study Arthritis Rheum 46 2287-2285

[6] McDonald D(2008)The risk of hospitalized infection in patients with rheumatoid arthritis J Rheumatol 35 387-3412

[7] Simon TA(2008)A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis Arthritis Res Ther 10 R45-1145

[8] Shaw Y(2015)Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis Arthritis Res Ther. 17 212-1764

[9] Zhang C(2005)The risk of lymphoma development in autoimmune diseases: a meta-analysis Arch Intern Med 165 2337-928

[10] Schumacher R(2006)Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2275-130

[1] Kvien TK(2004)Epidemiology and burden of illness of rheumatoid arthritis Pharmacoeconomics 22 1-12

[2] Shaw Y(2018)Responding resiliently to chronic disease: rheumatoid arthritis patients’ discourse on coping strategies and challenges Ann Rheum Dis 77 abstract FRI0740-HPR-2293

[3] Bradley M(2018)Understanding the burden of rheumatoid arthritis using qualitative research: which impacts are not captured by patient-reported measures? Ann Rheum Dis 77 abstract FRI0725-HPR-393

[4] Dominique A(2018)Understanding fatigue burden and coping strategies in rheumatoid arthritis using qualitative research Ann Rheum Dis 77 abstract AB1444-HPR-2344

[5] Michaud K(2002)Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study Arthritis Rheum 46 2287-2285

[6] McDonald D(2008)The risk of hospitalized infection in patients with rheumatoid arthritis J Rheumatol 35 387-3412

[7] Simon TA(2008)A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis Arthritis Res Ther 10 R45-1145

[8] Shaw Y(2015)Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis Arthritis Res Ther. 17 212-1764

[9] Zhang C(2005)The risk of lymphoma development in autoimmune diseases: a meta-analysis Arch Intern Med 165 2337-928

[10] Schumacher R(2006)Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2275-130